235 related articles for article (PubMed ID: 18033714)
1. Synthesis and characterization of cytidine derivatives that inhibit the kinase IspE of the non-mevalonate pathway for isoprenoid biosynthesis.
Crane CM; Hirsch AK; Alphey MS; Sgraja T; Lauw S; Illarionova V; Rohdich F; Eisenreich W; Hunter WN; Bacher A; Diederich F
ChemMedChem; 2008 Jan; 3(1):91-101. PubMed ID: 18033714
[TBL] [Abstract][Full Text] [Related]
2. Nonphosphate inhibitors of IspE protein, a kinase in the non-mevalonate pathway for isoprenoid biosynthesis and a potential target for antimalarial therapy.
Hirsch AK; Lauw S; Gersbach P; Schweizer WB; Rohdich F; Eisenreich W; Bacher A; Diederich F
ChemMedChem; 2007 Jun; 2(6):806-10. PubMed ID: 17361977
[No Abstract] [Full Text] [Related]
3. Inhibitors of the kinase IspE: structure-activity relationships and co-crystal structure analysis.
Hirsch AK; Alphey MS; Lauw S; Seet M; Barandun L; Eisenreich W; Rohdich F; Hunter WN; Bacher A; Diederich F
Org Biomol Chem; 2008 Aug; 6(15):2719-30. PubMed ID: 18633530
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (IspE) from Mycobacterium tuberculosis.
Shan S; Chen X; Liu T; Zhao H; Rao Z; Lou Z
FASEB J; 2011 May; 25(5):1577-84. PubMed ID: 21282208
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent inhibitors for IspF, an enzyme in the non-mevalonate pathway for isoprenoid biosynthesis and a potential target for antimalarial therapy.
Crane CM; Kaiser J; Ramsden NL; Lauw S; Rohdich F; Eisenreich W; Hunter WN; Bacher A; Diederich F
Angew Chem Int Ed Engl; 2006 Feb; 45(7):1069-74. PubMed ID: 16392111
[No Abstract] [Full Text] [Related]
6. Crystal structure of the bifunctional ATP sulfurylase-APS kinase from the chemolithotrophic thermophile Aquifex aeolicus.
Yu Z; Lansdon EB; Segel IH; Fisher AJ
J Mol Biol; 2007 Jan; 365(3):732-43. PubMed ID: 17095009
[TBL] [Abstract][Full Text] [Related]
7. Structure of 4-diphosphocytidyl-2-C- methylerythritol synthetase involved in mevalonate- independent isoprenoid biosynthesis.
Richard SB; Bowman ME; Kwiatkowski W; Kang I; Chow C; Lillo AM; Cane DE; Noel JP
Nat Struct Biol; 2001 Jul; 8(7):641-8. PubMed ID: 11427897
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
9. Nonmevalonate terpene biosynthesis enzymes as antiinfective drug targets: substrate synthesis and high-throughput screening methods.
Illarionova V; Kaiser J; Ostrozhenkova E; Bacher A; Fischer M; Eisenreich W; Rohdich F
J Org Chem; 2006 Nov; 71(23):8824-34. PubMed ID: 17081012
[TBL] [Abstract][Full Text] [Related]
10. Structure of 2C-methyl-d-erythritol-2,4-cyclodiphosphate synthase involved in mevalonate-independent biosynthesis of isoprenoids.
Steinbacher S; Kaiser J; Wungsintaweekul J; Hecht S; Eisenreich W; Gerhardt S; Bacher A; Rohdich F
J Mol Biol; 2002 Feb; 316(1):79-88. PubMed ID: 11829504
[TBL] [Abstract][Full Text] [Related]
11. Streptococcus pneumoniae isoprenoid biosynthesis is downregulated by diphosphomevalonate: an antimicrobial target.
Andreassi JL; Dabovic K; Leyh TS
Biochemistry; 2004 Dec; 43(51):16461-6. PubMed ID: 15610040
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the Plasmodium falciparum PK5 ATP-binding site: implications for the design of novel antimalarial agents.
Keenan SM; Welsh WJ
J Mol Graph Model; 2004 Jan; 22(3):241-7. PubMed ID: 14629982
[TBL] [Abstract][Full Text] [Related]
13. Structure-based drug design: exploring the proper filling of apolar pockets at enzyme active sites.
Zürcher M; Diederich F
J Org Chem; 2008 Jun; 73(12):4345-61. PubMed ID: 18510366
[TBL] [Abstract][Full Text] [Related]
14. (R)-3-Amidinophenylalanine-derived inhibitors of factor Xa with a novel active-site binding mode.
Mueller MM; Sperl S; Stürzebecher J; Bode W; Moroder L
Biol Chem; 2002; 383(7-8):1185-91. PubMed ID: 12437104
[TBL] [Abstract][Full Text] [Related]
15. Invariance and variability in bacterial PanK: a study based on the crystal structure of Mycobacterium tuberculosis PanK.
Das S; Kumar P; Bhor V; Surolia A; Vijayan M
Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):628-38. PubMed ID: 16699190
[TBL] [Abstract][Full Text] [Related]
16. The identification of isoprenoids that bind in the intersubunit cavity of Escherichia coli 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase by complementary biophysical methods.
Kemp LE; Alphey MS; Bond CS; Ferguson MA; Hecht S; Bacher A; Eisenreich W; Rohdich F; Hunter WN
Acta Crystallogr D Biol Crystallogr; 2005 Jan; 61(Pt 1):45-52. PubMed ID: 15608374
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and structural characterization of residue 96 mutants of Plasmodium falciparum triosephosphate isomerase: active-site loop conformation, hydration and identification of a dimer-interface ligand-binding site.
Gayathri P; Banerjee M; Vijayalakshmi A; Balaram H; Balaram P; Murthy MR
Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):847-57. PubMed ID: 19622869
[TBL] [Abstract][Full Text] [Related]
18. Plasmepsin inhibitors: design, synthesis, inhibitory studies and crystal structure analysis.
Kesavulu MM; Prakasha Gowda AS; Ramya TN; Surolia N; Suguna K
J Pept Res; 2005 Oct; 66(4):211-9. PubMed ID: 16138859
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of gamma-phosphono diester analogues of glutamate as highly potent inhibitors and active site probes of gamma-glutamyl transpeptidase.
Han L; Hiratake J; Kamiyama A; Sakata K
Biochemistry; 2007 Feb; 46(5):1432-47. PubMed ID: 17260973
[TBL] [Abstract][Full Text] [Related]
20. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
